HANGZHOU, China and SHAOXING, China, Nov. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today...
from PR Newswire: https://ift.tt/37NCA9l
No comments:
Post a Comment